ArmaGen, Inc., is a privately held biotechnology company focused on developing groundbreaking therapies for severe neurological disorders. The company is developing a robust pipeline of innovative therapies for the treatment of lysosomal storage disorders including neurological symptoms such as Hurler syndrome (MPS I), Hunter syndrome (MPS II), metachromatic leukodystrophy, Sanfilippo A and B syndromes, as well as other diseases with severe CNS manifestations. ArmaGen’s pipeline is based on decades of scientific leadership in engineering therapies to cross the blood-brain barrier and a dominant intellectual property portfolio. The company is advancing its pipeline through licensing and collaboration agreements, in-house development programs, and other partnering opportunities. For more information, visit www.armagen.com.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 26679 Agoura Road Suite 100, Calabasas,ca 91302,united States
- Phone
- 8182528214
- co****@****gen.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- armagen.com
- Keywords
- Blood-Brain barrier, MPS 1, MPS 2, AGT-181, AGT-182, AGT-183, AGT-184, Metachromatic leukodystrophy, MLD, Hunter syndrome, Hurler syndrome, CNS, BBB, Lysosomal storage diseases, LSDs, Mucopolysaccharidosis 1, Mucopolysaccharidosis 2.
- HQ
- Calabasas, CA
Armagen, Inc. Questions
Armagen, Inc.'s helpline number is 8182528214
Armagen, Inc.'s website is armagen.com
Armagen, Inc.'s LinkedIn profile is https://www.linkedin.com/company/armagen
Armagen, Inc. has
6 employees.
View email and phone details for 6
employees at Armagen, Inc..
Armagen, Inc.'s industry is
Biotechnology Research
Armagen, Inc.'s top competitors are
Vertex Pharmaceuticals,
Jcr Pharma,
Wave Life Sciences,
Armagen Technologies,
Jcr Pharmaceuticals,
Nektar Therapeutics,
クオリプス（株）,
Teva Pharmaceuticals,
Denali Therapeutics,
Jcr Biopharmaceuticals Inc.
Armagen, Inc.'s support email address is contact@armagen.com
Armagen, Inc.'s categories are Biotechnology Research
Armagen, Inc.'s founding year is 2003
